IDEXX Increases 2017 Outlook - Quick Facts

(RTTNews) - IDEXX Laboratories, Inc. (IDXX) increased its 2017 EPS outlook by $0.10 to $2.95 - $3.11 per share, reflecting an additional $0.10 benefit from the adoption of the new share-based compensation accounting guidance. The company raised 2017 revenue outlook by $15 million to $1.925 billion - $1.950 billion, reflecting an expectation for organic revenue growth of 9.5% - 11% and approximately a $5 million revenue benefit from updated assumptions related to foreign exchange rates.

First quarter EPS was $0.77, an increase of 51% compared to the first quarter 2016 on a reported basis, 53% on a constant currency basis and 29% when calculated to exclude the $0.12 of additional EPS attributable to the adoption of the new accounting guidance related to share-based compensation. Revenue increased 11% to $462 million.